The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe

INTRODUCTION: Prescribing guidance for disease-modifying treatment (DMT) in multiple sclerosis (MS) is centred on a clinical diagnosis of relapsing–remitting MS (RRMS). DMT prescription guidelines and monitoring vary across countries. Standardising the approach to diagnosis of disease course, for ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicholas, Richard, Rodgers, Jeff, Witts, James, Lerede, Annalaura, Friede, Tim, Hillert, Jan, Forsberg, Lars, Glaser, Anna, Manouchehrinia, Ali, Ramanujam, Ryan, Spelman, Tim, Klyve, Pernilla, Drahota, Jiri, Horakova, Dana, Joensen, Hanna, Pontieri, Luigi, Magyari, Melinda, Ellenberger, David, Stahmann, Alexander, Butzkueven, Helmut, Van Der Walt, Anneke, Bezlyak, Vladimir, Lines, Carol, Middleton, Rod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524069/
https://www.ncbi.nlm.nih.gov/pubmed/37771841
http://dx.doi.org/10.1177/17562864231198963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10524069/
https://www.ncbi.nlm.nih.gov/pubmed/37771841
http://dx.doi.org/10.1177/17562864231198963

Ejemplares similares